VirginiaRBartonMD

Dermatology • New Orleans, LA

Dermatology Resident

Join to view full profile

Dr. Barton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Barton's full profile

Already have an account?

Office
131 S. Robertson St.
Suite 1100
New Orleans, LA 70112
Is this information wrong?

Education & Training

Tulane UniversityResidency, Dermatology, 2021 - 2024
Medical University of South CarolinaClass of 2018
Prisma Health-Upstate/University of South Carolina School of Medicine GreenvilleInternship, Surgery

Certifications & Licensure

SC State Medical License 2018 - 2025
ME State Medical License 2024 - 2025
LA State Medical License 2021 - 2024
CA State Medical License 2019 - 2021

Clinical Trials

Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL) Start of enrollment: 2017 Nov 30
Completed
Phase 2, Phase 3
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD) Start of enrollment: 2015 Oct 15
Active, not recruiting
Phase 3
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata Start of enrollment: 2018 Sep 24
Active, not recruiting
Phase 2, Phase 3
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis Start of enrollment: 2018 Feb 20
Completed
Phase 3
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis Start of enrollment: 2018 Jun 27
Terminated
Phase 3
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis Start of enrollment: 2019 Dec 30
Active, not recruiting
Phase 3
Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis Start of enrollment: 2019 Jun 30
Completed
Phase 3
A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis Start of enrollment: 2019 May 01
Terminated
Phase 2
PRISM Study-Pruritus Relief Through Itch Scratch Modulation Start of enrollment: 2018 Aug 07
Completed
Phase 2, Phase 3
A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) Start of enrollment: 2020 Nov 17
Completed
Phase 3
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC Start of enrollment: 2018 Dec 21
Recruiting
Observational Evaluation of Atopic Dermatitis in Pediatric Patients Start of enrollment: 2019 Aug 15
Recruiting
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY) Start of enrollment: 2019 Apr 05
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa Start of enrollment: 2020 Mar 02
Completed
Phase 3
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis Start of enrollment: 2018 Dec 19
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

3 citations
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis:...
Gabriella Santa Lucia, Alan Snyder, Alex Drohan, Mathew J Gregoski, Virginia Barton, Dirk M Elston, Almeera Lateef> ;JAMA Dermatology. 2023 May 1
Disruption of the Medical Supply Chain by the COVID-19 Pandemic Adversely Affecting Dermatologic Surgery.
Gage Rensch, Virginia Barton, Patrick Ragland> ;Dermatologic Surgery. 2022 Apr 1
Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort study.
N Ezeh, K Ardalan, K A Buhr, C Nguyen, O Al Ahmed, S P Ardoin, V Barton, S Bell, H Brandling-Bennett, L Castelo-Soccio, Y E Chiu, B F Chong, D O Co, I Lara-Corrales, A...> ;Journal of the American Academy of Dermatology. 2022 Sep 1
3 citations
Successful Management of Anti-TNF-Induced Psoriasis Despite Continuation of Therapy in a Pyoderma Gangrenosum Patient
Atrin Toussi, Stephanie T. Le, Virgina R. Barton, Chelsea Ma, Michelle Y. Cheng, Andrea Sukhov, Reason Wilken, Forum Patel, Elizabeth A. Wang, Emanual Michael Maverakis> ;Journal of Drugs in Dermatology. 2020 Feb 1
35 citations
Treatment of Pediatric Alopecia Areata: A Systematic Review
Virginia R. Barton, Atrin Toussi, Smita Awasthi, Maija Ht Kiuru> ;Journal of the American Academy of Dermatology. 2021 Apr 30
13 citations
The cutaneous and intestinal microbiome in psoriatic disease
Stephanie T. Le, Atrin Toussi, Natalia Maverakis, Alina I. Marusina, Virgina R. Barton, Alexander A. Merleev, Guillaume Luxardi, Siba P. Raychaudhuri, Emanual Michael ...> ;Clinical Immunology. 2020 Sep 1
55 citations
Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review
Atrin Toussi, Virginia R. Barton, Stephanie T. Le, Oma N. Agbai, Maija Ht Kiuru> ;Journal of the American Academy of Dermatology. 2021 Jul 1
6 citations
Peristomal ulcers misdiagnosed as pyoderma gangrenosum: a common error
Virginia R. Barton, Stephanie T. Le, Jenny Z. Wang, Atrin Toussi, Apra Sood, Emanual Michael Maverakis> ;Journal of the European Academy of Dermatology and Venereology. 2020 Feb 1
1 citations
Non-surgical management of primary invasive melanoma.
Elizabeth A. Wang, Jason Kao, Chelsea Ma, Michelle Y. Cheng, Virginia R. Barton, Tatyana A. Petukhova, Maija Ht Kiuru, Emanual Michael Maverakis, Amanda Kirane> ;The Journal of Dermatological Treatment. 2021 Aug 18
3 citations
Transcriptome mining and B cell depletion support a role for B cells in psoriasis pathophysiology
Atrin Toussi, Alexander A. Merleev, Virginia R. Barton, Stephanie T. Le, Alina I. Marusina, Guillaume Luxardi, Joseph Kirma, Xianying Xing, Iannis E. Adamopoulos, Maxw...> ;Journal of Dermatological Science. 2019 Nov 19
6 citations
Epidemiology of Keratinocyte Carcinoma.
David M. Perry, Virginia Barton, Anthony J. Alberg> ;Current Dermatology Reports. 2017 May 29
39 citations
Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review
Virginia Barton, Kent Armeson, Shalaka S. Hampras, Laura K. Ferris, Kala Visvanathan, Dana E. Rollison, Anthony J. Alberg> ;Archives of Dermatological Research. 2017 Mar 11
Join now to see all

Hospital Affiliations

Tulane Medical CenterNew Orleans, Louisiana
Ochsner Medical CenterNew Orleans, Louisiana

VirginiaRBartonMD

Dr. Barton is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.